{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:23:18Z","timestamp":1789543398037,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health \u201cFondo de Investigaciones Sanitarias. Instituto de Salud Carlos III\u201d Madrid, Spain"},{"name":"European Regional Development Fund (FEDER) and European Union framework MSCA-RISE-H2020 Programme"},{"name":"Xunta de Galicia and FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain)"},{"DOI":"10.13039\/100009664","name":"Spanish Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.phrs.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T02:26:37Z","timestamp":1554431197000},"page":"51-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue"],"prefix":"10.1016","volume":"144","author":[{"given":"Alana","family":"Arag\u00f3n-Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Feij\u00f3o-Band\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Abella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Rosell\u00f3-Llet\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Portol\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Taraz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Bigazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Gualillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00001.2012","article-title":"Relaxin family peptides and their receptors","volume":"93","author":"Bathgate","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2019.04.009_bib0010","first-page":"598","article-title":"Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy","volume":"113","author":"Nonhoff","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/bph.13684","article-title":"Relaxin family peptides: structure-activity relationship studies","volume":"174","author":"Patil","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/157339912802083487","article-title":"Relaxin, insulin and diabetes: an intriguing connection","volume":"8","author":"Bani","year":"2012","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.phrs.2019.04.009_bib0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1074\/jbc.M114.589325","article-title":"Relaxin activates peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) through a pathway involving PPAR\u03b3 coactivator 1\u03b1 (PGC1\u03b1)","volume":"290","author":"Singh","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.04.009_bib0030","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.2337\/db13-0033","article-title":"Relaxin treatment reverses insulin resistance in mice fed a high-fat diet","volume":"62","author":"Bonner","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.diabres.2007.10.017","article-title":"Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus","volume":"79","author":"Szepietowska","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.phrs.2019.04.009_bib0040","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.clinbiochem.2013.08.007","article-title":"The plasma levels of relaxin-2 and relaxin-3 in patients with diabetes","volume":"46","author":"Zhang","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.phrs.2019.04.009_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clinbiochem.2012.09.018","article-title":"Relaxin-3 is associated with metabolic syndrome and its component traits in women","volume":"46","author":"Ghattas","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.phrs.2019.04.009_bib0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/bph.13778","article-title":"Recent progress in the understanding of relaxin family peptides and their receptors","volume":"174","author":"Summers","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1755-5922.12231","article-title":"Serelaxin in acute heart failure: most recent update on clinical and preclinical evidence","volume":"35","author":"Ghosh","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2019.04.009_bib0060","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ejhf.830","article-title":"Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study","volume":"19","author":"Teerlink","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2019.04.009_bib0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bph.13523","article-title":"The actions of relaxin on the human cardiovascular system","volume":"174","author":"Sarwar","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/bph.13695","article-title":"Serelaxin in clinical development: past, present and future","volume":"174","author":"Unemori","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cardfail.2016.10.016","article-title":"Evaluating the efficacy, safety, and tolerability of serelaxin when added to standard therapy in asian patients with acute heart failure: design and rationale of RELAX-AHF-ASIA trial","volume":"23","author":"Sato","year":"2017","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.phrs.2019.04.009_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2019.04.009_bib0085","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.tem.2018.02.008","article-title":"Heart disease and relaxin: new actions for an old hormone","volume":"29","author":"Devarakonda","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2019.04.009_bib0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure - implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12020-018-1534-3","article-title":"Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes","volume":"60","author":"Arag\u00f3n-Herrera","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.phrs.2019.04.009_bib0100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2019.04.009_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrendo.2016.169","article-title":"Sphingolipids and phospholipids in insulin resistance and related metabolic disorders","volume":"13","author":"Meikle","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbalip.2017.12.003","article-title":"Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies","volume":"1863","author":"Tham","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.04.009_bib0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.113.301646","article-title":"Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts","volume":"113","author":"Parikh","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0120","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.hrthm.2015.12.030","article-title":"Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels","volume":"13","author":"Henry","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.phrs.2019.04.009_bib0125","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/pr201223p","article-title":"Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression","volume":"11","author":"Barr","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jprot.2015.01.019","article-title":"Enhancing metabolomics research through data mining","volume":"127","author":"Mart\u00ednez-Arranz","year":"2015","journal-title":"J. Proteomics"},{"key":"10.1016\/j.phrs.2019.04.009_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-015-0819-z","article-title":"Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level","volume":"52","author":"Feij\u00f3o-Band\u00edn","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.phrs.2019.04.009_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5507\/bp.2017.002","article-title":"Adipokines and cardiovascular disease: a comprehensive review","volume":"161","author":"Smekal","year":"2017","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech."},{"key":"10.1016\/j.phrs.2019.04.009_bib0145","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.biopha.2018.09.165","article-title":"Adipokines in critical illness: a review of the evidence and knowledge gaps","volume":"108","author":"Alipoor","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2019.04.009_bib0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0022-2828(95)90080-2","article-title":"Organization and function of sarcolemmal phospholipids in control and ischemic\/reperfused cardiomyocytes","volume":"27","author":"Post","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1010905221770","article-title":"Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart","volume":"221","author":"Tappia","year":"2001","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2019.04.009_bib0160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbamem.2013.10.018","article-title":"Phospholipid methylation in mammals: from biochemistry to physiological function","volume":"1838","author":"Vance","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.04.009_bib0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.plipres.2009.12.002","article-title":"The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice","volume":"49","author":"Guillou","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.nutr.24.121803.063211","article-title":"Structure, function, and dietary regulation of \u03946, \u03945, and \u03949 desaturases","volume":"24","author":"Nakamura","year":"2004","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.phrs.2019.04.009_bib0175","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2015.08.101","article-title":"Identification of human ELOVL5 enhancer regions controlled by SREBP","volume":"465","author":"Shikama","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"February","key":"10.1016\/j.phrs.2019.04.009_bib0180","article-title":"The peptide hormone relaxin: from bench to bedside","author":"Jelinic","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ehjcvp\/pvv046","article-title":"Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection","volume":"2","author":"D\u00edez","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.phrs.2019.04.009_bib0190","doi-asserted-by":"crossref","first-page":"R559","DOI":"10.1152\/ajpregu.00306.2016","article-title":"Relaxin confers cytotrophoblast protection from hypoxia-reoxygenation injury through the phosphatidylinositol 3-kinase-Akt\/protein kinase B cell survival pathway","volume":"312","author":"Ogunleye","year":"2017","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0195","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and Metabolic Diseases: Where Do We Stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2019.04.009_bib0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11010-017-3203-x","article-title":"Comprehensive analysis of phospholipids in the brain, heart, kidney, and liver: brain phospholipids are least enriched with polyunsaturated fatty acids","volume":"442","author":"Choi","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2019.04.009_bib0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1139\/cjpp-2015-0300","article-title":"Mechanisms increasing n-3 highly unsaturated fatty acids in the heart","volume":"94","author":"Gl\u00fcck","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12933-017-0638-z","article-title":"Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection","volume":"16","author":"Russell","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0220","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/CIRCHEARTFAILURE.113.000744","article-title":"Delta-6-desaturase links polyunsaturated fatty acid metabolism with phospholipid remodeling and disease progression in heart failure","volume":"7","author":"Le","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2019.04.009_bib0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2016.12.003","article-title":"\u03c93-Polyunsaturated fatty acids for heart failure: effects of dose on efficacy and novel signaling through free fatty acid receptor 4","volume":"103","author":"O\u2019Connell","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0230","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1080\/10408398.2015.1126549","article-title":"Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome","volume":"57","author":"Tortosa-Caparr\u00f3s","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.phrs.2019.04.009_bib0235","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.celrep.2018.08.017","article-title":"Lipidomic profiles of the heart and circulation in response to exercise versus cardiac pathology: a resource of potential biomarkers and drug targets","volume":"24","author":"Tham","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2019.04.009_bib0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2016.03.007","article-title":"Marine omega-3 highly unsaturated fatty acids: from mechanisms to clinical implications in heart failure and arrhythmias","volume":"82","author":"Gl\u00fcck","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.02.012","article-title":"Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update","volume":"58","author":"Albracht-Schulte","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2019.04.009_bib0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MCO.0000000000000254","article-title":"Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis","volume":"19","author":"Zhang","year":"2016","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.phrs.2019.04.009_bib0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.plipres.2006.01.004","article-title":"Fatty acid elongases in mammals: their regulation and roles in metabolism","volume":"45","author":"Jakobsson","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13148-018-0545-5","article-title":"FADS1-FADS2 genetic polymorphisms are associated with fatty acid metabolism through changes in DNA methylation and gene expression","volume":"10","author":"He","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.phrs.2019.04.009_bib0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/me.2014-1201","article-title":"Role of sphingosine kinase\/S1P axis in ECM remodeling of cardiac cells elicited by relaxin","volume":"29","author":"Frati","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2017.01.002","article-title":"Sphingolipids and glycerophospholipids - the \"ying and yang\" of lipotoxicity in metabolic diseases","volume":"66","author":"Rodriguez-Cuenca","year":"2017","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0275","series-title":"Sphingolipids and Metabolic Disease","article-title":"Heart sphingolipids in health and disease","author":"Baranowski","year":"2011"},{"key":"10.1016\/j.phrs.2019.04.009_bib0280","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2337\/dbi18-0018","article-title":"Strong heart, low ceramides","volume":"67","author":"Holland","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2019.04.009_bib0285","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96203","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2019.04.009_bib0290","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1096\/fj.201700300R","article-title":"Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes","volume":"32","author":"Law","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.04.009_bib0295","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007931","article-title":"Ceramide remodeling and risk of cardiovascular events and mortality","volume":"7","author":"Peterson","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2019.04.009_bib0300","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/2193-1801-3-523","article-title":"Cardiac taurine and principal amino acids in right and left ventricles of patients with either aortic valve stenosis or coronary artery disease: the importance of diabetes and gender","volume":"3","author":"Lewis","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.phrs.2019.04.009_bib0305","first-page":"5102","article-title":"Protective effects of N(2)-L-alanyl-Lglutamine mediated by the JAK2\/STAT3 signaling pathway on myocardial ischemia reperfusion","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2019.04.009_bib0310","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/cvr\/cvr051","article-title":"Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle","volume":"91","author":"Nielsen","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","article-title":"Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion","volume":"56","author":"Zhang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2019.04.009_bib0320","doi-asserted-by":"crossref","first-page":"36749","DOI":"10.1038\/srep36749","article-title":"2-Aminobutyric acid modulates glutathione homeostasis in the myocardium","volume":"6","author":"Irino","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2019.04.009_bib0325","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00726-015-2110-2","article-title":"Impaired energy metabolism of the taurinedeficient heart","volume":"48","author":"Schaffer","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.phrs.2019.04.009_bib0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00726-017-2498-y","article-title":"Mass spectrometry-based metabolomics to identify taurine-modified metabolites in heart","volume":"50","author":"Ito","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.phrs.2019.04.009_bib0335","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1463-1326.2010.01302.x","article-title":"Central and peripheral administration of human relaxin-2 to adult male rats inhibits food intake","volume":"12","author":"McGowan","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2019.04.009_bib0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/en.2014-1743","article-title":"Sex-specific effects of relaxin-3 on food intake and brain expression of corticotropin-releasing factor in rats","volume":"156","author":"Lenglos","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2019.04.009_bib0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fnins.2017.00127","article-title":"Interactions of circadian rhythmicity, stress and orexigenic neuropeptide systems: implications for food intake control","volume":"11","author":"Blasiak","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2019.04.009_bib0350","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3389\/fphys.2017.00599","article-title":"Relaxin-2 in cardiometabolic diseases: mechanisms of action and future perspectives","volume":"8","author":"Feij\u00f3o-Band\u00edn","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0355","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1210\/en.2004-1532","article-title":"Central relaxin-3 administration causes hyperphagia in male Wistar rats","volume":"146","author":"McGowan","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2019.04.009_bib0360","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2016.06.008","article-title":"Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice","volume":"251","author":"Tiyerili","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2019.04.009_bib0365","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/bph.13530","article-title":"Sex-specific effects of relaxin-3 on food intake and body weight gain","volume":"174","author":"Calvez","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0370","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10799890600623373","article-title":"Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats","volume":"26","author":"Hida","year":"2006","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.phrs.2019.04.009_bib0375","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.regpep.2006.04.009","article-title":"Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats","volume":"136","author":"McGowan","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.phrs.2019.04.009_bib0380","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.009_bib0385","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-Neprilysin Axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.04.009_bib0390","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cvr\/cvx106","article-title":"The molecular mechanisms of obesity paradox","volume":"113","author":"Antonopoulos","year":"2017","journal-title":"Cardiovasc. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819303068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819303068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T02:40:41Z","timestamp":1565145641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819303068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":78,"alternative-id":["S1043661819303068"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.009","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}